Reviva Pharmaceuticals Holdings, Inc. Warrants (RVPHW)

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering

Reviva Pharmaceuticals announced a public offering of 27 million shares and accompanying warrants, raising approximately $9 million to fund research and development activities and working capital.